GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perseus Proteomics Inc (TSE:4882) » Definitions » Common Stock

Perseus Proteomics (TSE:4882) Common Stock : 円1,953.06 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Perseus Proteomics Common Stock?

Perseus Proteomics's quarterly common stock stayed the same from Jun. 2023 (円1,939.25 Mil) to Sep. 2023 (円1,939.25 Mil) but then increased from Sep. 2023 (円1,939.25 Mil) to Dec. 2023 (円1,953.06 Mil).

Perseus Proteomics's annual common stock increased from Mar. 2021 (円604.00 Mil) to Mar. 2022 (円1,939.25 Mil) but then stayed the same from Mar. 2022 (円1,939.25 Mil) to Mar. 2023 (円1,939.25 Mil).


Perseus Proteomics Common Stock Historical Data

The historical data trend for Perseus Proteomics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perseus Proteomics Common Stock Chart

Perseus Proteomics Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Common Stock
Get a 7-Day Free Trial 799.97 799.97 604.00 1,939.25 1,939.25

Perseus Proteomics Quarterly Data
Mar18 Mar19 Dec19 Mar20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,939.25 1,939.25 1,939.25 1,939.25 1,953.06

Perseus Proteomics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Perseus Proteomics (TSE:4882) Business Description

Traded in Other Exchanges
N/A
Address
4-7-6, Komaba, Tokyo Park Building, Meguro-ku, Tokyo, JPN, 153-0041
Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody based therapeutics and diagnostics drugs to cure against cancer and other diseases.

Perseus Proteomics (TSE:4882) Headlines

No Headlines